Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.38, $0.11 better than the analyst estimate of $0.27. Revenue for the quarter came in at $478.2 million versus the consensus estimate of $469.98 million.

GUIDANCE:

Bruker sees Q1 2016 EPS of $0.97-$1.02, versus the consensus of $0.91.

• For the full year 2016, Bruker expects organic revenue growth of approximately 3 percent. The Company expects to increase its 2016 non-GAAP operating profit margin by approximately 100 basis points year-over-year.

For earnings history and earnings-related data on Bruker (BRKR) click here.